Publications: DR James Pittaway
Detomas M, Kagan LR, Pittaway JFH, Schauer MP, Kloock S, Geiger N, Kimpel O, Fassnacht M et al.
(
2025
)
.
Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis
.
European Journal of Endocrinology
vol.
193
,
(
5
)
604
-
612
.
Cristofolini G, Detomas M, Puglisi S, Novizio R, Canu L, Lasolle H, Ceccato F, Angelousi A et al.
(
2025
)
.
OC31 - Prognostic value of serum inflammation-based scores in localized adrenocortical carcinoma undergoing adjuvant mitotane therapy: a multicenter ENSAT study
.
Mariniello K, Pittaway JFH, Altieri B, Borges KS, Hadjidemetriou I, Ribeiro C, Ruiz‐Babot G, Tourigny DS et al.
(
2025
)
.
Cover Image, Volume 45, Issue 6
.
vol.
45
,
is.
6
,
American Association for the Advancement of Science (AAAS)
Mariniello K, Pittaway JFH, Altieri B, Borges KS, Hadjidemetriou I, Ribeiro C, Ruiz‐Babot G, Tourigny DS et al.
(
2025
)
.
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma
.
Cancer Communications
vol.
45
,
(
6
)
663
-
668
.
Mangone A, Altieri B, Bancos I, Luconi M, Ziolkowska B, Nekic AB, Libe R, Ceccato F et al.
(
2025
)
.
38O Clinical predictors of treatment response in advanced adrenocortical carcinoma: A multicentre ENSAT study
.
Ng E, Goodchild E, Pittaway J, Hussain S
(
2024
)
.
Mind your PJPs and coombs
.
Endocrine Abstracts
Plowman CE, Soruna O, Pittaway J, Goodchild E, Chung T
(
2024
)
.
Non-islet cell tumour hypoglycaemia in adrenocortical carcinoma responding to combined growth hormone and corticosteroid therapy
.
Endocrine Abstracts
Smith D, Pittaway J, Berney D
(
2024
)
.
Peritoneal strumosis - balancing the management and preservation of fertility
.
Endocrine Abstracts
Detomas M, Ceccato F, Simeoli C, Dolce P, Aulinas MA, Gilis-Januszewska A, Parasiliti CM, Bassiony M et al.
(
2024
)
.
Comparison of metyrapone, osilodrostat and ketoconazole in the therapy of endogenous Cushing's syndrome: The MOSKETEER study
.
Endocrine Abstracts
Kimpel O, Altieri B, Laganà M, Vogl TJ, Adwan H, Pittaway J, Dischinger U, Quinkler M et al.
(
2024
)
.
The Value of Local Therapies in Advanced Adrenocortical Carcinoma
.
Cancers
vol.
16
,
(
4
)
Soruna O, Plowman C, Yu T, Pittaway J, Goodchild E, Wragg A, Fitchat T
(
2023
)
.
Laparoscopic adrenalectomy for phaeochromocytoma in the context of acute coronary syndrome
.
Endocrine Abstracts
Puglisi S, Calabrese A, Basile V, Kimpel O, Altieri B, Angelousi A, Kaltsas G, Ambroziak U et al.
(
2023
)
.
THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
.
Williams JL, Smith C, Hall C, Khaled Z, Maharaj A, Kwong R, Pittaway J, Casas J et al.
(
2023
)
.
Elevated sphingosine-1-phosphate lyase leads to increased metabolism and reduced survival in adrenocortical carcinoma
.
European Journal of Endocrinology
vol.
188
,
(
1
)
Kimpel O, Schindler P, Schmidt-Pennington L, Altieri B, Megerle F, Haak H, Pittaway J, Dischinger U et al.
(
2022
)
.
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma
.
British Journal of Cancer
vol.
128
,
(
4
)
586
-
593
.
Pittaway J, Mariniello K, Altieri B, Sbiera I, Sbiera S, Chung T-T, Abdel-Azziz T, Akker SA et al.
(
2022
)
.
Delta-like non-canonical Notch ligand 1 (DLK1) - a novel biomarker in adrenocortical carcinoma
.
Endocrine Abstracts
Mariniello K, Pittaway J, Hadjidemetriou I, Borges K, Doroszko M, Doghman M, Rahman N
(
2022
)
.
Delta-like non-canonical notch ligand 1 (DLK1)-expressing adrenocortical progenitor cells: role in adrenal turnover, remodeling and tumorigenesis in mice
.
Endocrine Abstracts
Guasti L, Pittaway JFH
(
2022
)
.
A new recipe for TARTs? One step closer in identifying the origin of testicular adrenal rest tumours
.
European Journal of Endocrinology
vol.
187
,
(
6
)
c3
-
c4
.
Williams J, Smith C, Hall C, Khaled Z, Maharaj A, Kwong R, Pittaway J, Casas J et al.
(
2022
)
.
Elevated SGPL1 expression is associated with increased metabolic rate in cells and reduced survival in individuals with adrenocortical carcinoma
.
Endocrine Abstracts
Pittaway JFH, Lipsos C, Guasti L
(
2021
)
.
The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer
.
Endocrine Related Cancer
vol.
28
,
(
12
)
r271
-
r287
.
Kimpel O, Paul S, Bülent P, Megerle F, Haak HR
(
2021
)
.
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC)
.
Endocrine Abstracts
Altieri B, Di Dato C, Modica R, Bottiglieri F, Di Sarno A, Pittaway JFH, Martini C, Faggiano A
(
2020
)
.
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
.
Nutrients
vol.
12
,
(
4
)
Pittaway JFH, Harrison C, Rhee Y, Holder-Espinasse M, Fryer AE, Cundy T, Drake WM
(
2019
)
.
Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review
.
vol.
14
,
is.
1
,
Springer Nature
Liew S-Y, Akker SA, Pittaway JFH
(
2019
)
.
Glucocorticoid replacement therapies: past, present and future
.
Current Opinion in Endocrine and Metabolic Research
vol.
8
,
152
-
159
.
Hadjidemetriou I, Mariniello K, Ruiz-Babot G, Pittaway J, Mancini A, Mariannis D, Gomez-Sanchez CE, Parvanta L et al.
(
2019
)
.
DLK1/PREF1 marks a novel cell population in the human adrenal cortex
.
The Journal of Steroid Biochemistry and Molecular Biology
vol.
193
,
Pittaway JFH
(
2019
)
.
Pathobiology and genetics of adrenocortical carcinoma
.
Journal of Molecular Endocrinology
vol.
62
,
(
2
)
r105
-
r119
.
Pittaway J, Drake W
(
2018
)
.
Acute onset DI in a young woman
.
Endocrine Abstracts
Pittaway J, Carpenter R
(
2018
)
.
Hyporeninaemic hypoaldosteronism in surgically cured Conn's syndrome
.
Endocrine Abstracts
Pittaway JFH, Harrison C, Rhee Y, Holder-Espinasse M, Fryer AE, Irving MD
(
2018
)
.
Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review
.
Orphanet Journal of Rare Diseases
vol.
13
,
(
1
)
Pittaway J, Sahdev A, Harrison B, Newell-Price J
(
2017
)
.
An unusual presentation of multiple endocrine neoplasia 1 (MEN1)
.
Endocrine Abstracts
Pittaway J, Shamash J
(
2017
)
.
Androgen deprivation in testicular cancer by way of macroprolactinoma - balancing the two pathologies
.
Endocrine Abstracts
Pittaway JF, Presern E, Rathod VS, Rathod KS, Deaner A
(
2015
)
.
Atrial flutter ablation in a case of diuretic resistant constrictive pericarditis
.
Indian Heart Journal
vol.
67
,
(
4
)
377
-
380
.
Pittaway JF, Srirangalingam U, Hanson PL
(
2014
)
.
Renal replacement therapy as a treatment for severe refractory hypercalcemia
.
Minerva Endocrinologica
vol.
39
,
(
3
)
231
-
233
.
Emmanuel J, Rathod K, Pittaway J, Mannan I, Mastan A
(
2014
)
.
PCV111 Physiological Parameters Can Help Guide Heart Failure Therapy
.
Value in Health
.
vol.
17
,
O'Toole S, Pittaway J, Raja O, Buckland M, Plowman N, Brennan C, Waterhouse M, Akker S et al.
(
2013
)
.
Prevalence of anti-thyroglobulin antibodies, their prognostic significance and impact on patient care in a cohort of patients with differentiated thyroid cancer
.
Endocrine Abstracts1
-
1
.
Snape A, Pittaway JF, Baker MD
(
2010
)
.
Excitability parameters and sensitivity to anemone toxin ATX‐II in rat small diameter primary sensory neurones discriminated by Griffonia simplicifolia isolectin IB4
.
The Journal of Physiology
vol.
588
,
(
1
)
125
-
137
.
Mangone A, Altieri B, Ferrante E, Bancos I, Luconi M, Ziołkowska B, Barač NA, Libe R et al.
.
Clinical predictors of treatment response in advanced adrenocortical carcinoma: a multicentre ENSAT study
.
Mariniello K, Pittaway JFH, Altieri B, Borges KS, Hadjidemetriou I, Ribeiro C, Ruiz-Babot G, Lim JA et al.
.
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma
.
O K, P S, L S-P, B A, F M, R S, J P, K M
.
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC)
.
Crona J, Baudin E, Amir HM, Kimpel O, Balderrama-Brondani V, Kroiss M, Lagana M, Dischinger U et al.
.
Outcome of combination chemotherapy for metastatic adrenocortical carcinoma
.
Puglisi S, Calabrese A, Basile V, Kimpel O, Altieri B, Kaltsas G, Ambroziak U, Appetecchia M et al.
.
Prolonged exposure to target mitotane concentrations is associated with better recurrence-free survival in patients with adrenocortical carcinoma on adjuvant treatment
.